Clinical Research Directory
Browse clinical research sites, groups, and studies.
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
Sponsor: University of North Carolina, Chapel Hill
Summary
This study will investigate the effects of woodsmoke (WS) exposure on human nasal mucosal immune responses to viral infection. The study tests the hypotheses that WS exposure modifies biomarkers of nasal mucosal immune function, increases in Live Attenuated Influenza Virus (LAIV) -induced nasal symptoms, and reduces mucosal antibody production.
Official title: The Effects of Woodsmoke Exposure on Nasal Immune Responses to Influenza Infection in Normal Human Volunteers
Key Details
Gender
All
Age Range
18 Years - 49 Years
Study Type
INTERVENTIONAL
Enrollment
112
Start Date
2025-09-26
Completion Date
2028-12-31
Last Updated
2026-04-30
Healthy Volunteers
Yes
Conditions
Interventions
LAIV nasal vaccine is chosen as a model viral infection
Inoculation with LAIV
Wood smoke
Wood smoke exposure concentrations at 500 ug/m3 for two hours.
Placebo for LAIV nasal vaccine is chosen as a model viral infection
Placebo for LAIV inoculation. Nasal administration of normal saline.
Placebo for Wood Smoke (clean Air Exposure)
Clean Air Exposure for 2 hours
Locations (1)
Mary Ellen Jones
Chapel Hill, North Carolina, United States